Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the production of antidepressants such as selective serotonin reuptake inhibitors (SSRIs). Its structure, featuring a 4-fluorophenyl ring along with amino and hydroxyl functional groups, supports the development of bioactive molecules that can cross the blood-brain barrier and facilitate binding and interaction with biological targets like serotonin receptors. Commonly employed in research settings for designing new drug candidates targeting central nervous system disorders, including depression and anxiety. Also utilized in the preparation of chiral building blocks for asymmetric synthesis, enhancing the efficiency and selectivity of drug manufacturing processes.